Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Big fines unlikely to steer drug companies from marketing drugs for unapproved uses
Big fines unlikely to steer drug companies from marketing drugs for unapproved uses
Big fines unlikely to steer drug companies from marketing drugs for unapproved uses
Submitted by
admin
on September 5, 2009 - 12:37pm
Source:
Yahoo/AP
News Tags:
off-label
Pfizer
Bextra
Headline:
Big fines unlikely to steer drug companies from marketing drugs for unapproved uses
Do Not Allow Advertisers to Use My Personal information
